These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 22030384

  • 1. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P, Kimmig R, Kubista E, Biglia N, Egberts J, Mulder R, Planellas J, Moggio G, Mol-Arts M, Kenemans P.
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [Abstract] [Full Text] [Related]

  • 2. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    Kroiss R, Fentiman IS, Helmond FA, Rymer J, Foidart JM, Bundred N, Mol-Arts M, Kubista E.
    BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
    [Abstract] [Full Text] [Related]

  • 3. Short and long term effects of tibolone in postmenopausal women.
    Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD008536. PubMed ID: 22336846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V, Marata AM, Magrini N, D'Amico R, Bassi C, Maestri E.
    Cochrane Database Syst Rev; 2016 Oct 12; 10(10):CD008536. PubMed ID: 27733017
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
    Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW, LIBERATE Study Group.
    Lancet Oncol; 2009 Feb 12; 10(2):135-46. PubMed ID: 19167925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.
    Maturitas; 2013 Feb 12; 74(2):172-8. PubMed ID: 23201326
    [Abstract] [Full Text] [Related]

  • 9. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C, Keramopoulos D, Vourli G, Gaki V, Bredakis N, Keramopoulos A.
    Climacteric; 2005 Dec 12; 8(4):342-51. PubMed ID: 16390769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V, Perreault S, Lachaine J.
    Maturitas; 2007 Oct 20; 58(2):138-49. PubMed ID: 17870259
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-response analysis of effects of tibolone on climacteric symptoms.
    Landgren MB, Bennink HJ, Helmond FA, Engelen S.
    BJOG; 2002 Oct 20; 109(10):1109-14. PubMed ID: 12387462
    [Abstract] [Full Text] [Related]

  • 18. Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy.
    Palomba S, Di Carlo C, Morelli M, Russo T, Noia R, Nappi C, Mastrantonio P, Zullo F.
    Maturitas; 2003 Aug 20; 45(4):267-73. PubMed ID: 12927313
    [Abstract] [Full Text] [Related]

  • 19. The influence of tibolone on quality of life in postmenopausal women.
    Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ.
    Maturitas; 2002 Jan 30; 41(1):35-43. PubMed ID: 11809341
    [Abstract] [Full Text] [Related]

  • 20. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
    Lipov EG, Joshi JR, Sanders S, Wilcox K, Lipov S, Xie H, Maganini R, Slavin K.
    Lancet Oncol; 2008 Jun 30; 9(6):523-32. PubMed ID: 18485819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.